IOV-Istituto Oncologico

Padova 35128

0 studies enrolling now · 1 studies all time

What they study most

PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer

Studies at this site

• Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) — Running, not enrolling